...
首页> 外文期刊>癌と化学療法 >A case of unresectable gastric cancer complicated by serious pyloric stenosis in which s-1 administration after gastrojejunostomy proved effective.
【24h】

A case of unresectable gastric cancer complicated by serious pyloric stenosis in which s-1 administration after gastrojejunostomy proved effective.

机译:通过严重的幽门狭窄复杂的胃癌的案例,其中S-1在GastrojejunoStomy证明后的S-1给药有效。

获取原文
获取原文并翻译 | 示例
           

摘要

We report a patient with unresectable gastric cancer who was effectively treated with S-1 after gastrojejunostomy. A 64-year-old man was referred to our hospital for anorexia and epigastricpalpable mass. Upper gastrointestinal endoscopy revealed an ulcerous tumor in the antrum of the stomach, and gastric roentgenography showed pyloric stenosis. CT showed simultaneous multiple liver metastases. We performed gastrojejunostomy to allow oral intake. He was treated with daily oral administration of 120-80 mg S-1 for two weeks followed by one week rest as one course. The treatment was repeated for 19 courses until remission was observed. Weekly paclitaxel therapy (80 mg/m(2)/week) was then chosen as second-line chemotherapy. Administration was continued for three weeks with one-week rest. The treatment course was repeated for 6 courses. Bi-weekly administration of CPT-11 (80 mg) and CDDP (30 mg) was chosen as third-line chemotherapy. He died of progressive disease 2 years and 2 months after surgery. During chemotherapy, he maintained a performance status of 0 to 1, and maintained quality of life. This case suggested that the gastrojejunostomy was a useful method for treating unresectable gastric cancer, allowing the possibility of oral intake, and the use of S-1.
机译:我们在GastrojeNunoStomy之后报告了未切除的胃癌的患者,在S-1中有效处理。一个64岁的男子被称为厌食症和epigastricpalpable质量的医院。上胃肠内镜内窥镜检查显示胃窦中的溃疡肿瘤,胃泌素术显示幽门狭窄。 CT显示同时多发性肝转移。我们进行了GastrojejunoStomy以允许口服摄入量。他被每日口服给药120-80 mg S-1治疗两周,然后作为一门课程休息一周。重复治疗19种疗程,直至观察到缓解。然后选择每周紫杉醇治疗(80 mg / m(2)/周)作为二线化疗。一周休息,行政管理部门持续了三周。治疗课程重复6个课程。双每周施用CPT-11(80mg)和CDDP(30mg)作为第三线化疗。他在手术后2岁和2个月死亡。在化疗过程中,他保持了0到1的性能状态,并保持了生活质量。这种情况表明,GastrojejunoStomyy是治疗不可切除的胃癌的有用方法,允许口服摄入和使用S-1的可能性。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号